BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This highly complex material comprises epithelial cell adhesion molecule-targeted aptamer (SYL3C) functionalized gypenoside (Gyp) loaded liposomes (SYL3C-Gyp@LPs). The structural matrix incorporates the hydrophobic triterpenoid saponin gypenoside (Gyp) within the hydrocarbon domain of a stable phospholipid bilayer, while the external boundary is covalently functionalized with synthetic SYL3C oligonucleotidic aptamers targeted to epithelial cell adhesion molecules (EpCAM). This advanced configuration introduces a dense, highly specialized oligonucleotidic surface topography paired with an amphiphilic saponin-loaded core. The resulting aptamer-functionalized nanoparticles exhibit high colloidal stability and a highly uniform spherical morphology.
Source
Custom synthesis
Functional Group
EpCAM-targeted aptamer SYL3C; Gypenoside
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.